Answers are grounded in this paper and cite their sources.
Analysis reveals ASCL1 expression changes in C4-2 prostate cancer cells with altered PROX1, suggesting epigenetic mechanisms in tumor progression.
Supplementary Figure 7 - ASCL1 expression upon PROX1 WT or indicated mutant stable overexpression in C4-2 PRAD model as compared to control cells expressing empty vector.
No takes yet. Share an insight, caveat, or question.
Venkadakrishnan et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: